Edward Maldonado

3PUBLICATIONS
36CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 26, 2024
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170).

Edward Maldonado, W Kimryn Rathmell, Geoffrey I Shapiro

|Sep 13, 2021
Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy.

David A Bond, Jeffrey M Switchenko, Diego Villa

|Sep 28, 2020
Estimation of US patients with cancer who may respond to cytotoxic chemotherapy.

Edward B Maldonado, Scott Parsons, Emerson Y Chen

Pageof 1